亚太药业
(002370)
| 流通市值：65.54亿 | | | 总市值：65.54亿 |
| 流通股本：7.46亿 | | | 总股本：7.46亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 587,809,931.97 | 625,177,565.07 | 776,793,031.37 | 743,850,694.68 |
| 交易性金融资产 | 30,082,329.42 | - | - | - |
| 应收票据及应收账款 | 103,548,761.89 | 96,912,265.35 | 89,445,228.74 | 95,309,526.3 |
| 应收账款 | 103,548,761.89 | 96,912,265.35 | 89,445,228.74 | 95,309,526.3 |
| 应收款项融资 | 28,969,559.17 | 35,415,795.84 | 32,410,018.25 | 16,367,501.71 |
| 预付款项 | 1,346,589.33 | 1,212,353.75 | 1,397,897.48 | 3,099,599.07 |
| 其他应收款合计 | 3,309,405.58 | 719,557.06 | 14,827,334.18 | 16,142,967.87 |
| 其中:应收利息 | 2,730,243.04 | 165,000 | - | - |
| 存货 | 52,774,054.96 | 68,697,542.16 | 80,217,397.39 | 70,128,529.14 |
| 其他流动资产 | 8,142,638.68 | 8,824,454.12 | 9,538,216.27 | 10,261,570.55 |
| 流动资产合计 | 815,983,271 | 836,959,533.35 | 1,004,629,123.68 | 955,160,389.32 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 36,689,365.37 | 39,108,543.87 | 36,747,170.59 | 38,485,729.8 |
| 固定资产 | 300,034,190.33 | 304,887,691.33 | 330,860,741.29 | 338,078,979.81 |
| 在建工程 | 1,457,149.83 | 552,500 | 297,500 | 29,220 |
| 无形资产 | 43,291,544.3 | 44,658,478.28 | 52,746,936.45 | 54,195,160.47 |
| 开发支出 | 16,463,412.82 | 16,463,412.82 | 15,618,009.04 | 15,618,009.04 |
| 长期待摊费用 | 28,080 | 56,160 | 150,660 | 200,880 |
| 非流动资产合计 | 397,963,742.65 | 405,726,786.3 | 436,421,017.37 | 446,607,979.12 |
| 资产总计 | 1,213,947,013.65 | 1,242,686,319.65 | 1,441,050,141.05 | 1,401,768,368.44 |
| 流动负债: | | | | |
| 短期借款 | - | - | 30,026,583.33 | 30,055,583.33 |
| 应付票据及应付账款 | 50,020,424.53 | 69,063,495.48 | 66,631,806.78 | 45,765,335.37 |
| 其中：应付票据 | 15,348,965 | 33,887,283.7 | 18,538,318.7 | - |
| 应付账款 | 34,671,459.53 | 35,176,211.78 | 48,093,488.08 | 45,765,335.37 |
| 合同负债 | 2,138,035.77 | 2,188,118.63 | 6,315,614.21 | 2,233,319.42 |
| 应付职工薪酬 | 7,600,219.47 | 6,794,698.13 | 6,413,471.04 | 11,869,414.21 |
| 应交税费 | 1,965,646.47 | 3,320,837.95 | 998,567.03 | 5,370,960.37 |
| 其他应付款合计 | 17,455,571.62 | 18,063,999.59 | 48,882,214.68 | 19,154,466.61 |
| 一年内到期的非流动负债 | - | 0 | 270,459,833.1 | 301,697,044.76 |
| 其他流动负债 | 277,944.65 | 284,455.42 | 821,029.85 | 290,331.53 |
| 流动负债合计 | 79,457,842.51 | 99,715,605.2 | 430,549,120.02 | 416,436,455.6 |
| 非流动负债: | | | | |
| 应付债券 | - | 0 | - | - |
| 预计负债 | 6,037,827.67 | 6,037,827.67 | 4,933,357.37 | 4,933,357.37 |
| 递延收益 | 3,494,197.66 | 3,777,511 | 4,060,824.34 | 4,360,565.93 |
| 递延所得税负债 | 3,783,077.92 | 3,999,850.29 | 3,645,644.31 | 3,856,985.92 |
| 非流动负债合计 | 13,315,103.25 | 13,815,188.96 | 12,639,826.02 | 13,150,909.22 |
| 负债合计 | 92,772,945.76 | 113,530,794.16 | 443,188,946.04 | 429,587,364.82 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 745,667,530 | 745,667,530 | 739,627,912 | 728,586,186 |
| 其他权益工具 | - | - | 56,321,681 | 63,352,923.19 |
| 资本公积 | 2,005,016,546.65 | 2,005,016,546.65 | 1,936,419,835.7 | 1,906,946,915.41 |
| 其他综合收益 | - | - | - | 0 |
| 盈余公积 | 60,559,514.31 | 60,559,514.31 | 60,559,514.31 | 60,559,514.31 |
| 未分配利润 | -1,690,069,523.07 | -1,682,088,065.47 | -1,795,067,748 | -1,787,264,535.29 |
| 归属于母公司股东权益合计 | 1,121,174,067.89 | 1,129,155,525.49 | 997,861,195.01 | 972,181,003.62 |
| 股东权益合计 | 1,121,174,067.89 | 1,129,155,525.49 | 997,861,195.01 | 972,181,003.62 |
| 负债和股东权益合计 | 1,213,947,013.65 | 1,242,686,319.65 | 1,441,050,141.05 | 1,401,768,368.44 |
| 公告日期 | 2025-10-29 | 2025-08-30 | 2025-04-30 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |